Literature DB >> 33293845

Identification of Reactive Hypoglycemia with Different Basic BMI and Its Causes by Prolonged Oral Glucose Tolerance Test.

Xue Lv1, Kun Fang2, Wenqing Hao1, Yuxin Han1, Nailong Yang1, Qing Yu1.   

Abstract

PURPOSE: To identify the population susceptible to reactive hypoglycemia and explain the possible reasons for their susceptibility.
METHODS: Ninety-four patients were divided into normal weight, overweight and obese groups before a 75-gram prolonged oral glucose tolerance test (POGTT). The incidence of reactive hypoglycemia (blood glucose ≤3.1 mmol/L or 55 mg/dL at points of 0-4 hours) was compared among three groups, and blood glucose and insulin levels were monitored simultaneously from 0 - 4 hours to assess the level of insulin resistance and insulin sensitivity. Furthermore, the degree of insulin resistance among three groups and within each subgroup (whether hypoglycemia events occurred) was compared.
RESULTS: Among the three groups, the incidence of hypoglycemia was significantly different at 3 (P=0.033) and 4 hours (P=0.020). At 4 hours, the incidence of reactive hypoglycemia in the obese group was approximately 3 times that in the normal weight group. The insulin level in obese group at 4 hours was nearly 4 times higher than that in normal group, and the same result also exists in the same subgroup of different groups. In addition, the hypoglycemia subgroup of obese group had higher insulin level than non-hypoglycemia (P=0.000). The homeostasis model assessment of insulin resistance index increased with increasing BMI among the three groups (P=0.000), while the Matsuda index decreased (P=0.000). The comparison of the homeostasis model assessment of insulin resistance index between subgroups in each group showed that the P values were 0.021, 0.038 and 0.085, successively, and the P values for the Matsuda index were 0.019, 0.013 and 0.119, respectively.
CONCLUSION: Obese people has higher rate of reactive hypoglycemia than other groups in POGTT, in which insulin resistance may play an important role. But patients who are evaluated for reactive hypoglycemia need to be observed for at least 3 or 4 hours.
© 2020 Lv et al.

Entities:  

Keywords:  insulin resistance; low-carb ketogenic diet; prolonged oral glucose tolerance test; reactive hypoglycemia

Year:  2020        PMID: 33293845      PMCID: PMC7719337          DOI: 10.2147/DMSO.S280084

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  28 in total

1.  Implications of World Health Organization classification for body mass index on the correlations between common electrocardiographic indexes for left ventricular hypertrophy and left ventricular mass.

Authors:  Satoshi Kurisu; Hiroki Ikenaga; Noriaki Watanabe; Tadanao Higaki; Takashi Shimonaga; Ken Ishibashi; Yoshihiro Dohi; Yukihiro Fukuda; Yasuki Kihara
Journal:  Clin Exp Hypertens       Date:  2016-12-12       Impact factor: 1.749

Review 2.  Postprandial reactive hypoglycemia.

Authors:  J F Brun; C Fedou; J Mercier
Journal:  Diabetes Metab       Date:  2000-11       Impact factor: 6.041

3.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

Review 4.  Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Authors:  Christopher J Nolan; Neil B Ruderman; Steven E Kahn; Oluf Pedersen; Marc Prentki
Journal:  Diabetes       Date:  2015-03       Impact factor: 9.461

5.  [Reactive hypoglycemia - an interdisciplinary approach of the disease of XXI Century].

Authors:  Marianna Hall; Magdalena Walicka; Iwona Traczyk
Journal:  Wiad Lek       Date:  2020

Review 6.  Hypoglycemia in Diabetes Mellitus.

Authors:  Barbara Freeland
Journal:  Home Healthc Now       Date:  2017-09

7.  Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice.

Authors:  F Isken; M O Weickert; M H Tschöp; R Nogueiras; M Möhlig; A Abdelrahman; S Klaus; B Thorens; A F Pfeiffer
Journal:  Diabetologia       Date:  2009-07-31       Impact factor: 10.122

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 9.  Hyperinsulinemia: a Cause of Obesity?

Authors:  Karel A Erion; Barbara E Corkey
Journal:  Curr Obes Rep       Date:  2017-06

10.  Delay in glucose peak time during the oral glucose tolerance test as an indicator of insulin resistance and insulin secretion in type 2 diabetes patients.

Authors:  Xinlei Wang; Xiaoqin Zhao; Ranran Zhou; Yunjuan Gu; Xiaohui Zhu; Zhuqi Tang; Xinlu Yuan; Wei Chen; Rongping Zhang; Chen Qian; Shiwei Cui
Journal:  J Diabetes Investig       Date:  2018-04-20       Impact factor: 4.232

View more
  2 in total

1.  Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients.

Authors:  Kai-Fang Hua; Ming-You Zhang; Yao Zhang; Bing-Jie Ren; Yan-Hui Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-09       Impact factor: 3.249

2.  Atherosclerosis Risk Factors in Patients with Reactive Hypoglycemia.

Authors:  Małgorzata Landowska; Agata Żebrowska; Konrad Fajer; Patrycja Adamek; Aleksandra Kruk; Bernadetta Kałuża; Edward Franek
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-14       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.